These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37646075)

  • 1. Protective effects of Saccharomyces boulardii CNCM I-745 in an experimental model of NSAID-induced enteropathy.
    Simon O'Brien E; Robert A; Gauthier D; Le Cavorzin A; Planchais J; Roux X; Verleye M; Castagné V
    Benef Microbes; 2023 Sep; 14(3):239-253. PubMed ID: 37646075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Saccharomyces boulardii CNCM I-745 as therapeutic strategy for prevention of nonsteroidal anti-inflammatory drug-induced intestinal injury.
    D'Antongiovanni V; Antonioli L; Benvenuti L; Pellegrini C; Di Salvo C; Calvigioni M; Panattoni A; Ryskalin L; Natale G; Banni S; Carta G; Ghelardi E; Fornai M
    Br J Pharmacol; 2023 Dec; 180(24):3215-3233. PubMed ID: 37519261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microbiota-derived metabolite indole decreases mucosal inflammation and injury in a murine model of NSAID enteropathy.
    Whitfield-Cargile CM; Cohen ND; Chapkin RS; Weeks BR; Davidson LA; Goldsby JS; Hunt CL; Steinmeyer SH; Menon R; Suchodolski JS; Jayaraman A; Alaniz RC
    Gut Microbes; 2016 May; 7(3):246-61. PubMed ID: 27007819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling.
    Yoshikawa K; Kurihara C; Furuhashi H; Takajo T; Maruta K; Yasutake Y; Sato H; Narimatsu K; Okada Y; Higashiyama M; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Tajiri H; Hokari R
    J Gastroenterol; 2017 Jan; 52(1):61-71. PubMed ID: 27075753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota in NSAID Enteropathy: New Insights From Inside.
    Wang X; Tang Q; Hou H; Zhang W; Li M; Chen D; Gu Y; Wang B; Hou J; Liu Y; Cao H
    Front Cell Infect Microbiol; 2021; 11():679396. PubMed ID: 34295835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NSAID enteropathy: could probiotics prevent it?
    Montalto M; Gallo A; Gasbarrini A; Landolfi R
    J Gastroenterol; 2013 Jun; 48(6):689-97. PubMed ID: 22875474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of bile in pathogenesis of indomethacin-induced enteropathy.
    Jacob M; Foster R; Sigthorsson G; Simpson R; Bjarnason I
    Arch Toxicol; 2007 Apr; 81(4):291-8. PubMed ID: 17151867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy.
    Fornai M; Pellegrini C; Benvenuti L; Tirotta E; Gentile D; Natale G; Ryskalin L; Colucci R; Piccoli E; Ghelardi E; Blandizzi C; Antonioli L
    Nutrition; 2020 Feb; 70():110583. PubMed ID: 31739175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of NSAID enteropathy as shown by a simple faecal test.
    Tibble JA; Sigthorsson G; Foster R; Scott D; Fagerhol MK; Roseth A; Bjarnason I
    Gut; 1999 Sep; 45(3):362-6. PubMed ID: 10446103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial: the effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy - a randomized, double-blind, cross-over, placebo-controlled study.
    Montalto M; Gallo A; Curigliano V; D'Onofrio F; Santoro L; Covino M; Dalvai S; Gasbarrini A; Gasbarrini G
    Aliment Pharmacol Ther; 2010 Jul; 32(2):209-14. PubMed ID: 20384610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study.
    Bustos Fernández LM; Man F; Lasa JS
    Dig Dis; 2023; 41(5):798-809. PubMed ID: 36630947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers.
    Kabbani TA; Pallav K; Dowd SE; Villafuerte-Galvez J; Vanga RR; Castillo NE; Hansen J; Dennis M; Leffler DA; Kelly CP
    Gut Microbes; 2017 Jan; 8(1):17-32. PubMed ID: 27973989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NSAID enteropathy and bacteria: a complicated relationship.
    Syer SD; Blackler RW; Martin R; de Palma G; Rossi L; Verdu E; Bercik P; Surette MG; Aucouturier A; Langella P; Wallace JL
    J Gastroenterol; 2015 Apr; 50(4):387-93. PubMed ID: 25572030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota Mediates Protection Against Enteropathy Induced by Indomethacin.
    Xiao X; Nakatsu G; Jin Y; Wong S; Yu J; Lau JY
    Sci Rep; 2017 Jan; 7():40317. PubMed ID: 28067296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FFA3 Activation Stimulates Duodenal Bicarbonate Secretion and Prevents NSAID-Induced Enteropathy via the GLP-2 Pathway in Rats.
    Said H; Akiba Y; Narimatsu K; Maruta K; Kuri A; Iwamoto KI; Kuwahara A; Kaunitz JD
    Dig Dis Sci; 2017 Aug; 62(8):1944-1952. PubMed ID: 28523577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of proteinase-activated receptors 1 and 2 in nonsteroidal anti-inflammatory drug enteropathy.
    Fornai M; Colucci R; Pellegrini C; Benvenuti L; Natale G; Ryskalin L; Blandizzi C; Antonioli L
    Pharmacol Rep; 2020 Oct; 72(5):1347-1357. PubMed ID: 32583327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peyer's patches play a protective role in nonsteroidal anti-inflammatory drug-induced enteropathy in mice.
    Hiyama S; Iijima H; Shinzaki S; Inoue T; Shiraishi E; Kawai S; Araki M; Kato M; Hayashi Y; Nishida T; Fujii H; Mukai A; Shibata N; Sato S; Kiyono H; Gotoh K; Motooka D; Nakamura S; Iida T; Tsujii M; Takehara T
    Inflamm Bowel Dis; 2014 May; 20(5):790-9. PubMed ID: 24651581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity of
    Czerucka D; Rampal P
    World J Gastroenterol; 2019 May; 25(18):2188-2203. PubMed ID: 31143070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective Effect of Luminal Uric Acid Against Indomethacin-Induced Enteropathy: Role of Antioxidant Effect and Gut Microbiota.
    Wada A; Higashiyama M; Kurihara C; Ito S; Tanemoto R; Mizoguchi A; Nishii S; Inaba K; Sugihara N; Hanawa Y; Horiuchi K; Shibuya N; Akiyama M; Okada Y; Watanabe C; Komoto S; Tomita K; Takei F; Hokari R
    Dig Dis Sci; 2022 Jan; 67(1):121-133. PubMed ID: 33569665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present status and strategy of NSAIDs-induced small bowel injury.
    Higuchi K; Umegaki E; Watanabe T; Yoda Y; Morita E; Murano M; Tokioka S; Arakawa T
    J Gastroenterol; 2009; 44(9):879-88. PubMed ID: 19568687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.